Physician profile
Brian Frederic Wilner
NPI 1487867313
$1,288.20
in general payments reported to CMS, 2019-2025
20 companies · $116 in 2025
The $116 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $351 · 2020: $120 · 2021: $253 · 2022: $150 · 2023: $181 · 2024: $118 · 2025: $116.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $415.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $415.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $179.53 | 2022-2025 | Cobalt Dr Mri Surescan, Azure Xt Dr Mri Surescan |
| Amgen INC. | $163.86 | 2021 | |
| Novartis Pharmaceuticals Corporation | $115.87 | 2019-2025 | |
| Boston Scientific Corporation | $113.85 | 2019-2024 | Watchman Flx |
| Janssen Pharmaceuticals, INC | $112.43 | 2019-2021 | |
| Pfizer INC. | $105.46 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $76.75 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $57.88 | 2023-2024 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $56.26 | 2020-2022 | |
| Astrazeneca Pharmaceuticals LP | $54.25 | 2019-2023 | Farxiga |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $45.37 | 2019-2023 | Lifevest |
| Biosense Webster, INC. | $39.22 | 2023 | Carto 3 |
| Merck Sharp & Dohme LLC | $33.95 | 2021-2023 | Verquvo |
| Heartflow, INC. | $28.73 | 2025 | |
| Amarin Pharma, INC. | $24.08 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $21.12 | 2025 | Nimbl, Flexitouch Plus |
| Esperion Therapeutics, INC. | $20.03 | 2024 | Nexletol |
| Actelion Pharmaceuticals US, INC. | $14.28 | 2019 | |
| Biotronik INC. | $13.41 | 2019 | |
| Impulse Dynamics (USA) INC. | $11.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Wilner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.